Stay updated with breaking news from Recommendation Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Acceleron Pharma Inc. (Nasdaq: XLRN), a publicly traded biopharmaceutical company, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Acceleron for $180 per share ...
Sanofi to Acquire Translate Bio; Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development — Accelerates development of current Sanofi licensed programs in vaccines and potential to explore other therapeutic areas — — Fast tracks establishment of Sanofi’s recently announced mRNA Center of Excellence — — Full integration upgrades drug formulation capabilities and enhances US talent in a promising new technology — PARIS and LEXINGTON, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) — As part of Sanofi’s endeavor to accelerate the application of messenger RNA ...
/PRNewswire/ -- Thoma Bravo and Talend (NASDAQ: TLND) ("Talend or "the Company") today announced that Thoma Bravo has commenced the previously-announced tender...
NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- Iconix Brand Group, Inc. (NASDAQ:ICON) ("Iconix" or the "Company") today announced it has entered into a ...
Accelerates Growth Strategy by Adding Two Mid- to Late-Stage Product Candidates: Pelabresib (CPI-0610) and CPI-0209 Bolsters Position in Hematology-Oncology and Expands into Solid Tumors Best-in-Class